join us
CN
Home page
About Us
Profile
Affiliates/Subsidiaries
Development History
Quality Management
Contact Us
Legal Statement
Privacy Statement
Adverse Reaction Report
Science and Technology
R&D platform
R&D pipeline
Therapeutic Field
International Business
APIs
Finished Products
Medical device
Download product list
Contact
News Center
News & Trends
Public information
Learn latest news of our company
follow developments of our company
News & Trends
10
2026-08
Salubris’Innovative siRNA Drug SAL0195 Approved fo...
23
2026-07
Salubris Announces Acceptance of New Drug Applicat...
10
2026-07
Salubris Receives NMPA Clinical Trial Approval for...
22
2026-05
Shenzhen Salubris Pharmaceuticals Receives Accepta...
17
2026-05
Salubris’innovative biologic Xinfutai Plus® approv...
Learn more News & Trends